Legal & General Group PLC Eli Lilly & CO Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legal & General Group PLC holds 7,115,785 shares of LLY stock, worth $6.24 Billion. This represents 1.46% of its overall portfolio holdings.

Number of Shares

7,115,785

Previous 7,111,571 0.06%

Holding current value

$6.24 Billion

Previous $5.53 Billion 16.45%

% of portfolio

1.46%

Previous 1.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $3.05 Million - $3.83 Million	4,214 Added 0.06%	7,115,785 $6.44 Billion
Q1 2024 Jul 01, 2024	BUY	$592.2 - $792.28 $34.7 Million - $46.4 Million	58,566 Added 0.83%	7,111,571 $5.53 Billion
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $47.6 Million - $63.7 Million	-80,394 Reduced 1.13%	7,053,005 $5.49 Billion
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $635 Million - $748 Million	1,208,594 Added 20.4%	7,133,399 $4.16 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $79.3 Million - $109 Million	-182,455 Reduced 2.99%	5,924,805 $3.18 Billion
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $68.8 Million - $92.1 Million	196,292 Added 3.32%	6,107,260 $2.86 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $34.3 Million - $40.3 Million	110,469 Added 1.9%	5,910,968 $2.03 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $42.6 Million - $49.7 Million	-132,605 Reduced 2.24%	5,800,499 $2.12 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $91.1 Million - $104 Million	-307,204 Reduced 4.92%	5,933,104 $1.92 Billion
Q2 2022 Aug 22, 2022	SELL	$278.73 - $327.27 $15.6 Million - $18.3 Million	-56,000 Reduced 0.89%	6,240,308 $2.02 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $82.6 Million - $103 Million	351,755 Added 5.92%	6,296,308 $1.8 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $14.8 Million - $18.4 Million	-65,852 Reduced 1.1%	5,944,553 $1.64 Billion
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $30.9 Million - $38 Million	139,476 Added 2.38%	6,010,405 $1.39 Billion
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $41.8 Million - $54 Million	231,301 Added 4.1%	5,870,929 $1.35 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $20.2 Million - $26.2 Million	-123,203 Reduced 2.14%	5,639,628 $1.05 Billion
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $9.09 Million - $12 Million	69,686 Added 1.22%	5,762,831 $973 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $18.4 Million - $21.3 Million	-126,174 Reduced 2.17%	5,693,145 $843 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $2.17 Million - $2.61 Million	-15,926 Reduced 0.27%	5,819,319 $955 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $21.5 Million - $26.6 Million	180,486 Added 3.19%	5,835,245 $809 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $8.83 Million - $10.9 Million	82,593 Added 1.48%	5,654,759 $743 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2.32 Million - $2.52 Million	21,718 Added 0.39%	5,572,166 $623 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $7.7 Million - $8.99 Million	-69,532 Reduced 1.24%	5,550,448 $615 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $74.7 Million - $87.9 Million	671,128 Added 13.56%	5,619,980 $729 Million
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $25.2 Million - $28.2 Million	237,632 Added 5.04%	4,948,852 $573 Million
Q3 2018 Nov 20, 2018	BUY	$85.86 - $107.31 $2.71 Million - $3.39 Million	31,617 Added 0.68%	4,711,220 $506 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $2.73 Million - $3.14 Million	-36,105 Reduced 0.77%	4,679,603 $399 Million
Q1 2018 May 17, 2018	SELL	$74.21 - $87.6 $20.7 Million - $24.4 Million	-278,553 Reduced 5.58%	4,715,708 $365 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $409 Million - $439 Million	4,994,261	4,994,261 $422 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Eli Lilly & CO Transaction History